In line with this, KD of ADAM9 in HCT116 cells drastically reduced phospho-S6K, a signature mTOR target that facilitates tumor invasion including CRC invasion (32, 33, 34), without affecting total S6K levels (Fig. 4D and S4A). This evidence concerns the gene ADAM9 and colorectal carcinoma.